We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Wireless Pressure Sensor for Heart Failure Monitoring

By HospiMedica staff writers
Posted on 19 Jan 2007
A miniature wireless sensor implanted using minimally-invasive techniques transmits cardiac output, blood pressure, and heart rate data. More...


The CardioMEMS wireless heart failure (HF) sensor is a miniature device designed to improve the management of severe chronic cardiovascular diseases such as aneurysms, HF, and hypertension. The sensor is delivered to the patient's pulmonary artery using a simple catheter based procedure. The pulmonary artery pressure is then measured and displayed using CardioMEMS' proprietary electronic monitoring system, and the pressure data is transmitted wirelessly to a secure database and is then available for review on the company's website. In addition, the pressure waveform can be automatically sent and displayed on a personal digital assistant (PDA) for remote viewing. The data provided by the sensor allows adjustment of medications to alleviate symptoms before they are severe enough to warrant hospitalization. The HF sensor is a product of CardioMEMS (Atlanta, GA, USA).

MicroElectroMechanical Systems (MEMS) technology uses semiconductor industry techniques to create micron scale machines incorporating both mechanical and electronic components. A key circuit element of the sensor is a capacitor composed of two electrically interfaced conducting plates separated by an air gap. Pressure changes alter the distance between capacitor plates which changes the known resonant frequency. An electronic monitoring device detects this change and converts it into a pressure change reading.

"I was impressed by the ease of implantation of the sensor and use of the system,” said Philip Adamson, M.D., director of the Heart Failure Institute at the Oklahoma Heart Hospital (OHH, Oklahoma City, OK, USA), where the first two patients in the United States were implanted with the device. "Heart failure is the primary cause of hospitalization in the United States, and I am hopeful that the information derived from the CardioMEMS system can help reduce the number of hospitalizations and improve the quality of life of these patients.”



Related Links:
CardioMEMS
Oklahoma Heart Hospital

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.